Inti Bangun Sejahtera Tbk. vs Merck Tbk. — how do they compare? Inti Bangun Sejahtera Tbk. trades at Rp8,475 (market cap 11.45T), while Merck Tbk. trades at Rp3,900 (market cap 1.76T, 63K 24h volume). The key difference: Inti Bangun Sejahtera Tbk. is far larger — about 6.5× Merck Tbk.'s market cap. Which is the better fit depends on your goals.
| IBST | MERK | |
|---|---|---|
Market Cap | 11.45T | 1.76T |
Volume | — | 63K |
Lot | — | 630 |
Turnover | — | 243.97M |
Average Price | — | 3,872.46 |
Value | — | 243.97M |
Indicative Equilibrium Price | — | 3,900 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Inti Bangun Sejahtera Tbk formerly PT Inti Build Prosperous Tbk was established based on Notarial Deed No. 7 dated 28 April 2006 of Yulia, S.H., a notary in Jakarta.At first PT Inti Build Prosperous, Tbk provide signal amplification in buildings (in building system solution). Since the year 2009, PT Inti Build Prosperity has been providing telecommunication infrastructure such as telecommunications tower (tower providers) to meet the needs of mobile telecom operators in Indonesia. And at this time (July 2012) PT Inti Build Prosperity has 1.989 telecommunications tower.Currently, PT Inti Build Prosperous, Tbk provides services for several telecom operators, such as Smart Telecom, Indosat, Telkomsel, XL Axiata, Telkom Flexi, NTS, HCPT, Bakrie Telecom, through leasing tower spread throughout Indonesia.
Read more on IBST →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →